InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2454

Thursday, 01/17/2019 1:06:56 PM

Thursday, January 17, 2019 1:06:56 PM

Post# of 3283
I've been saying on the Yahoo board that SPPI has been a TWO drug company for the last 2 years. SPPI just gained maximum flexibility and leverage to go forward alone or negotiate a BO.

I continue to believe that they know the Zenith20 cohort 1 ORR and that it's great. My guess is 60% +/- 10% is likely and 70%+ is possible. I think the SD will be close to 100% and the mPFS will be 8+months.

JT seem extremely confident in their ability to position and sell Rolontis. He claims that their models always included up to three generics.

From what we know only a major miss-step can derail us-possible (witness the BTD), still unlikely.

In any event this just got a lot more interesting and REAL.

One year from now SPPI is going to be a whole different company.